Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1839]
News [4199]
Articles [376]
Editorials [10]
Conferences [104]
elearning [29]
Benefits and challenges of using PARP inhibitors to treat metastatic breast...
Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA
Benefits and challenges of using PARP inhibitors to treat metastatic breast cancer ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )
8 May 2019
A clinical nurse specialist led multidisciplinary approach to breast cancer...
Colleen Zombek - Ohiohealth, Columbus, USA
A clinical nurse specialist led multidisciplinary approach to breast cancer survivorship ( Colleen Zombek - Ohiohealth, Columbus, USA )
8 May 2019
Providing safe care to hereditary cancer patients and families
Suzanne Mahon - Saint Louis University, Missouri, USA
Providing safe care to hereditary cancer patients and families ( Suzanne Mahon - Saint Louis University, Missouri, USA )
8 May 2019
Biomarkers of systemic inflammation linked to reduced clinical activity of...
Luciana Molinero - Genentech, San Francisco, USA
Biomarkers of systemic inflammation linked to reduced clinical activity of atezolizumab monotherapy in metastatic TNBC ( Luciana Molinero - Genentech, San Francisco, USA )
18 Apr 2019
KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after...
Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea
KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after two or more lines of prior therapy ( Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea )
15 Apr 2019
Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative...
Dr Constantia Pantelidou - Dana Farber Cancer Institute, Boston, USA
Immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer ( Dr Constantia Pantelidou - Dana Farber Cancer Institute, Boston, USA )
15 Apr 2019
Talimogene laherparepvec combined with neoadjuvant chemotherapy for non...
Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA
Talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer ( Dr Hatem Soliman - Moffitt Cancer Centre, Tampa, USA )
15 Apr 2019
Trends in breast cancer incidence and risk
Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA
Trends in breast cancer incidence and risk ( Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA )
15 Apr 2019
The epidemiological shift of cancer
Dr Antonella Brunello - Istituto Oncologico Veneto, Padova, Italy
The epidemiological shift of cancer ( Dr Antonella Brunello - Istituto Oncologico Veneto, Padova, Italy )
21 Mar 2019
Breast cancer trials and the ageing population
Dr Etienne Brain - Institut Curie, Paris, France
Breast cancer trials and the ageing population ( Dr Etienne Brain - Institut Curie, Paris, France )
21 Mar 2019
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer
Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas...
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas Mottet )
15 Feb 2019
BGICC 2019
BGICC 2019 ( )
28 Jan 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation